March 2, 2010 (FinancialWire) — ChromaDex Corp. (OTCBB: CDXC), a firm that provides phytochemical reference standards and contract testing services, said it has received a U.S. General Services Administration supply contract for scientific services.

Effective March 1, the contract is meant to streamline the process by which federal agencies can engage ChromaDex and purchase services, including all aspects of dietary supplement testing, analytical method development and validation, contract research services, report and manuscript preparation and laboratory technique training.

California-based ChromaDex is engaged in the development of phytochemical and botanical reference standards and the creation of associated intellectual property.

ChromaDex provides the dietary supplement, food, beverage, nutraceutical and cosmetic industries with analytical tools, products, and services to meet regulatory, quality, efficacy and safety standards for their products.

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.